Affiliation:
1. National Institute of Pharmaceutical Education and Research (NIPER), Ahmedabad 382355, India
2. Department of Pharmaceutics and Drug Delivery, School of Pharmacy, The University of Mississippi, Oxford, MS 38677, USA
3. Center for Biomedical Research, Population Council, New York, NY 10065, USA
Abstract
Nucleic acid therapeutics, specifically antisense oligonucleotides (ASOs), can effectively modulate gene expression and protein function, leading to long-lasting curative effects. The hydrophilic nature and large size of oligonucleotides present translational challenges, which have led to the exploration of various chemical modifications and delivery systems. The present review provides insights into the potential role of liposomes as a drug delivery system for ASOs. The potential benefits of liposomes as an ASO carrier, along with their method of preparation, characterization, routes of administration, and stability aspects, have been thoroughly discussed. A novel perspective in terms of therapeutic applications of liposomal ASO delivery in several diseases such as cancer, respiratory disease, ophthalmic delivery, infectious diseases, gastrointestinal disease, neuronal disorders, hematological malignancies, myotonic dystrophy, and neuronal disorders remains the major highlights of this review.
Reference118 articles.
1. Delivery of Oligonucleotides with Lipid Nanoparticles;Wang;Adv. Drug Deliv. Rev.,2015
2. The current landscape of nucleic acid therapeutics;Kulkarni;Nat. Nanotechnol.,2021
3. Kerlin, R.L., and Li, X. (2013). Haschek and Rousseaux’s Handbook of Toxicologic Pathology, Elseiver.
4. Advances in oligonucleotide drug delivery;Roberts;Nat. Rev. Drug Discov.,2020
5. Jacob, D. (2023, March 13). How Do Antisense Oligonucleotides Work?. Available online: https://www.rxlist.com/neurologics_antisense_oligonucleotides/drug-class.htm.
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献